Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation

L.A. Jason,A.A. Mirin
DOI: https://doi.org/10.1080/21641846.2021.1878716
2021-01-02
Fatigue: Biomedicine, Health and Behavior
Abstract:<span>We update the US prevalence and economic impact estimates of the 2015 National Academy of Medicine report on myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), taking into account growth in population, economic inflation, and inclusion of children. We find a rough doubling of the ME/CFS prevalence and economic impact figures in the US, with low-end prevalence coming out to 1.5 million and economic impact having a range of 36–51 billion dollars per year.</span>
What problem does this paper attempt to address?